The epigenetic origin of aneuploidy

Current Genomics

Volumn 9, Issue 1, 2008, Pages 43-50

  Herrera, Luis A ^a   Prada, Diddier ^a   Andonegui, Marco A ^a   Dueñas González, Alfonso ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Aneuploidy; Cancer; Chromosome instability; Epigenetics

Indexed keywords

ARSENITE SODIUM; AURORA A KINASE; CADMIUM; CYANOCOBALAMIN; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; FOLIC ACID; HISTONE; HISTONE METHYLTRANSFERASE; NICKEL; RAP1 PROTEIN; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2;

ADAPTATION; ANEUPLOIDY; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER RESISTANCE; CARCINOGENESIS; CELL CLONING; CELL DIVISION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CHROMOSOME LOSS; CORRELATION ANALYSIS; CPG ISLAND; CYANOCOBALAMIN DEFICIENCY; DNA METHYLATION; DNA SEQUENCE; ENVIRONMENTAL EXPOSURE; EPIGENETICS; FOLIC ACID DEFICIENCY; GENE SILENCING; GENETIC SELECTION; GENETIC STABILITY; HUMAN; IN VIVO STUDY; INHERITANCE; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; NUTRITIONAL DEFICIENCY; PROMOTER REGION; PROTEIN MODIFICATION; RADIATION EXPOSURE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 41549161985     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920208783884883     Document Type: Review

References (95)

1. Gollin, S.M. Mechanisms leading to chromosomal instability. Semin. Cancer Biol. 2005, 15: 33-42.
2. Feinberg, A.P. Phenotypic plasticity and the epigenetics of human disease. Nature 2007, 447: 433-440.
3. Lengauer, C., Kinzler, K.W., Vogelstein, B. Genetic instabilities in human cancers. Nature 1998, 396: 643-649.
4. Yuan, B., Xu, Y., Woo, J.H., Wang, Y., Bae, Y.K., Yoon, D.S., Wersto, R.P., Tully, E., Wilsbach, K., Gabrielson, E. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin. Cancer Res. 2006, 12: 405-410.
5. Anand, S., Penrhyn-Lowe, S., Venkitaraman, A.R. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003, 3: 51-62.
6. Pihan, G.A., Wallace, J., Zhou, Y., Doxsey, S.J. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 2003, 63: 1398-1404.
7. D'Assoro, A.B., Lingle, W.L., Salisbury, J.L. Centrosome amplification and the development of cancer. Oncogene 2002, 21: 6146-6153.
8. Takai, N., Hamanaka, R., Yoshimatsu, J., Miyakawa, I. Polo-like kinases (Plks) and cancer. Oncogene 2005, 24: 287-291.
9. Zhou, B.B., Elledge, S.J. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408: 433-439.
10. Smith, L., Liu, S.J., Goodrich, L., Jacobson, D., Degnin, C., Bentley, N., Carr, A., Flaggs, G., Keegan, K., Hoekstra, M., Thayer, M.J. Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest. Nat. Genet. 1998, 19: 39-46.
11. Bassing, C.H., Sub, H., Ferguson, D.O., Chua, K.F., Mains, J., Eckersdorff, M., Gleason, M., Bronson, R., Lee, C., Alt, F.W. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 2003, 114: 359-370.
12. Weaver, Z., Montagna, C., Xu, X., Howard, T., Gadina, M., Brodie, S.G., Deng, C.X., Ried, T. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Oncogene 2002, 21: 5097-5107.
13. Wang, Z., Cummins, J.M., Shen, D., Cahill, D.P., Jallepalli, P.V., Wang, T.L., Parsons, D.W., Traverso, G., Awad, M., Silliman, N., Ptak, J., Szabo, S., Willson, J.K., Markowitz, S.D., Goldberg, M.L., Karess, R., Kinzler, K.W., Vogelstein, B., Velculescu, V.E., Lengauer, C. Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res. 2004, 64: 2998-3001.
14. der-Sarkissian, H., Bacchetti, S., Cazes, L., Londono-Vallejo, J.A. The shortest telomeres drive karyotype evolution in transformed cells. Oncogene 2004, 23: 1221-1228
15. Reid, B.J., Haggitt, R.C., Rubin, C.E., Rabinovitch, P.S. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 1987, 93: 1-11.
16. Levine, D.S., Rabinovitch, P.S., Haggitt, R.C., Blount, P.L., Dean, P.J., Rubin, C.E., Reid, B.J. Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 1991, 101: 1198-1210.
17. Storchova, Z., Pellman, D. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell. Biol. 2004, 5: 45-54.
18. Minhas, K.M., Singh, B., Jiang, W.W., Sidransky, D., Califano, J.A. Spindle assembly checkpoint defects and chromosomal instability in head and neck squamous cell carcinoma. Int. J. Cancer 2003, 107: 46-52.
19. Cahill, D.P., Lengauer, C., Yu, J., Riggins, G.J., Willson, J.K., Markowitz, S.D., Kinzler, K.W., Vogelstein, B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392: 300-303.
20. Doak, S.H., Jenkins, G.J., Parry, E.M., Griffiths, A.P., Baxter, J.N., Parry, J.M. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression. Mutat. Res. 2004, 547: 133-144.
21. Wu, C.W., Chi, C.W., Huang, T.S. Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer. World J. Gastroenterol. 2004, 10: 3240-3244.
22. Wassmann, K., Benezra, R. Mitotic checkpoints: from yeast to cancer. Curr. Opin. Genet. Dev. 2001, 11: 83-90.
23. Costello, J.F., Plass, C. Methylation matters. J. Med. Genet. 2001, 38: 285-303.
24. Fuks, F. DNA methylation and histone modifications: teaming up to silence genes. Curr. Opin. Genet. Dev. 2005, 15: 490-495.
25. Vertino, P.M., Issa, J.P., Pereira-Smith, O.M., Baylin, S.B. Stabilization of DNA methyltransferase levels and CpG island hypermethylation precede SV40-induced immortalization of human fibroblasts. Cell Growth Differ. 1994, 5: 1395-1402.
26. Brenner, C., Fuks, F. DNA methyltransferases: facts, clues, mysteries. Curr. Top. Microbiol. Immunol. 2006, 301: 45-66.
27. Hermann, A., Gowher, H., Jeltsch, A. Biochemistry and biology of mammalian DNA methyltransferases. Cell. Mol. Life Sci. 2004, 61: 2571-2587.
28. Rhee, I., Jair, K.W., Yen, R.W., Lengauer, C., Herman, J.G., Kinzler, K.W., Vogelstein, B., Baylin, S.B., Schuebel, K.E. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 2000, 404: 1003-1007.
29. Bird, A.P., Wolffe, A.P. Methylation-induced repression: belts, braces, and chromatin. Cell 1999, 99: 451-454.
30. Schübeler, D., Lorinez, M.C., Cimbora, D.M., Telling, A., Feng, Y.Q., Bouhassira, E.E., Groudine, M. Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol. Cell Biol. 2000, 20: 9103-9112.
31. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N., Strouboulis, J., Wolffe, A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 1998, 19: 187-191.
32. Tuck-Muller, C.M., Narayan, A., Tsien, F., Smeets, D.F., Sawyer, J., Fiala, E.S., Sohn, O.S., Ehrlich, M. DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet. Cell Genet. 2000, 89: 121-128.
33. Dodge, J.E., Okano, M., Dick, F., Tsujimoto, N., Chen, T., Wang, S., Ueda, Y., Dyson, N., Li, E. Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J. Biol. Chem. 2005, 280: 17986-17991.
34. Bourc'his, D., Bestor, T.H. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 2004, 431: 96-99.
35. Hata, K., Kusumi, M., Yokomine, T., Li, E., Sasaki, H. Meiotic and epigenetic aberrations in Dnmt3L-deficient male germ cells. Mol. Reprod. Dev. 2006, 73: 116-122.
36. Von Hoff, D.D., Slavik, M., Muggia, F.M. 5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia. Ann. Intern. Med. 1976, 85: 237-245.
37. Lavia, P., Ferraro, M., Micheli, A., Olivieri, G. Effect of 5-azacytidine (5-azaC) on the induction of chromatid aberrations (CA) and sister-chromatid exchanges (SCE). Mutat. Res. 1985, 149: 463-467.
38. Hernandez, R., Frady, A., Zhang, X.Y., Varela, M., Ehrlich, M. Preferential induction of chromosome 1 multibranched figures and whole-arm deletions in a human pro-B cell line treated with 5-azacytidine or 5-azadeoxycytidine. Cytogenet. Cell Genet. 1997, 76: 196-201.
39. Rodriguez, M.J., Lopez, M.A., Garcia-Orad, A., Vig, B.K. Sequence of centromere separation: effect of 5-azacytidine-induced epigenetic alteration. Mutagenesis 2001, 16: 109-114.
40. Fauth, E., Scherthan, H., Zankl, H. Frequencies of occurrence of all human chromosomes in micronuclei from normal and 5-azacytidine-treated lymphocytes as revealed by chromosome painting. Mutagenesis 1998, 13: 235-241.
41. Guttembach, M., Schmid, M. Exclusion of specific Human Chromosomes into micronuclei by 5-azacytidine Treatment of lymphocyte culture. Exp. Cell. Res. 1994, 211: 127-132.
42. Kokalj-Vokac, N., Almeida, A., Viegas-Pequignot, E., Jeanpierre, M., Malfoy, B., Dutrillaux, B. Specific induction of uncoiling and recombination by azacytidine in classical satellite-containing constitutive heterochromatin. Cytogenet. Cell Genet. 1993, 63: 11-15.
43. Albanesi, T., Polani, S., Cozzi, R., Perticone, P. DNA strand methylation and sister chromatid exchanges in mammalian cells in vitro. Mutat. Res. 1999, 429: 239-248.
44. Perticone, P., Palitti, F., Cozzi, R., D'Erme, M., Bona, R. Persistence of azacytidine-induced SCEs and genomic methylation in CHO cells in vitro. Mutat. Res. 1990, 245: 211-215.
45. Habib, M., Fares, F., Bourgeois, C.A., Bella, C., Bernardino, J., Hernandez-Blazquez, F., de Capoa, A., Niveleau, A. DNA global hypomethylation in EBV-transformed interphase nuclei. Exp. Cell Res. 1999, 249: 46-53.
46. Sciandrello, G., Caradonna, F., Mauro, M., Barbata, G. Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis 2004, 25: 413-417.
47. Blackburn, E.H. Switching and signaling at the telomere. Cell 2001, 106: 661-673.
48. Gonzalo, S., Jaco, I., Fraga, M.F., Cehn, T., Li, E., Esteller, M., Blasco, M.A. DNA methyltrasferases control telomere lenght and telomere recombination in mammalian cells. Nat. Cell Biol. 2006, 8: 416-424.
49. Bailey, S., Murnane, J.P. Telomeres, chromosome instability and cancer. Nuc. Ac. Res. 2006, 34: 2408-2417.
50. Garcia-Cao, M., O'Sullivan, R., Peters, A.H., Jenuwein, T., Blasco, M.A. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet. 2004, 36: 94-99.
51. Garcia-Cao, M., Gonzalo, S., Dean, D., Blasco, M.A. A role for the Rb family of proteins in controlling telomere length. Nat. Genet. 2002, 32: 415-419.
52. Brock, G.J., Charlton, J., Bird, A. Densely methylated sequences that are preferentially localized at telomere-proximal regions of human chromosomes. Gene 1999, 240: 269-277.
53. Bensaada, M., Kiefer, H., Tachdjian, G., Lapierre, J.M., Cacheux, V., Niveleau, A., Metezeau, P. Altered patterns of DNA methylation on chromosomes from leukemia cell lines: identification of 5-methylcytosines by indirect inummodetection. Cancer Genet. Cytogenet. 1998, 103: 101-109.
54. de Lange, T., Shiue, L., Myers, R.M., Cox, D.R., Naylor, S.L., Killery, A.M., Varmus, H.E. Structure and variability of human chromosome ends. Mol. Cell Biol. 1990, 10: 518-527.
55. Gisselsson, D., Shao, C., Tuck-Muller, C.M., Sogorovic, S., Palsson, E., Smeets, D., Ehrlich, M. Interphase chromosomal abnormalities and mitotic missegregation of hypomethylated sequences in ICF syndrome cells. Chromosoma 2005, 114: 118-126.
56. Meeker, A.K., Hicks, J.L., Iacobuzio-Donahue, C.A., Montgomery, E.A., Westra, W.H., Chan, T.Y., Ronnett, B.M., De Marzo, A.M. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res. 2004, 10: 3317-3326.
57. Fouladi, B., Sabatier, L., Miller, D., Pottier, G., Murnane, J.P. The relationship between spontaneous telomere loss and chromosome instability in a human tumor cell line. Neoplasia 2000, 2: 540-554.
58. Pantic, M., Zimmermann, S., El Daly, H., Opitz, O.G., Popp, S., Boukamp, P., Martens, U.M. Telomere dysfunction and loss of p53 cooperate in defective mitotic segregation of chromosomes in cancer cells. Oncogene 2006, 25: 4413-4420.
59. Ehrlich, M. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. J. Nutr. 2002, 132: 2424S-2429S
60. Ma, Y., Jacobs, S.B., Jackson-Grusby, L., Mastrangelo, M.A., Torres-Betancourt, J.A., Jaenisch, R., Rasmussen, T.P. DNA CpG hypomethylation induces heterochromatin reorganization involving the histone variant macroH2A. J. Cell Sci. 2005, 118: 1607-1616.
61. Ehrlich, M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin. Immunol. 2003, 109: 17-28.
62. Zhang, R., Liu, S.T., Chen, W., Bonner, M., Pehrson, J., Yen, T.J., Adams, P.D. HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol. Cell Biol. 2007, 27: 949-962.
63. Lehnertz, B., Ueda, Y., Derijck, A.A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., Peters, A.H. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 2003, 13: 1192-1200.
64. Melcher, M., Schmid, M., Aagaard, L., Selenko, P., Laible, G., Jenuwein, T. Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression. Mol. Cell Biol. 2000, 20: 3728-3741.
65. Peters, A.H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., Opravil, S., Doyle, M., Sibilia, M., Jenuwein, T. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001, 107: 323-337.
66. Nakagawa, T., Kanai, Y., Ushijima, S., Kitamura, T., Kakizoe, T., Hirohashi, S. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas. J. Urol. 2005, 173: 243-246.
67. Qu, G., Dubeau, L., Narayan, A., Yu, M.C., Ehrlich, M. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutat. Res. 1999, 423: 91-101.
68. Xie, Z.H., Huang, Y.N., Chen, Z.X., Riggs, A.D., Ding, J.P., Gowher, H., Jeltsch, A., Sasaki, H., Hata, K., Xu, G.L. Mutations in DNA methyltransferase DNMT3B in ICF syndrome affect its regulation by DNMT3L. Hum. Mol. Genet. 2006, 15: 1375-1385.
69. Miniou, P., Bourc'his, D., Molina-Gomes, D., Jeanpierre, M., Viegas-Pequignot, E. Undermethylation of Alu sequences in ICF syndrome: molecular and in situ analysis. Cytogenet. Cell Genet. 1997, 77: 308-313.
70. Hassan, K.M., Norwood, T., Gimelli, G., Gartler, S.M., Hansen, R.S. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication. Hum. Gen. 2001, 109: 452-462.
71. Kondo, T., Bobek, M.P., Kuick, R., Lamb, B., Zhu, X., Narayan, A., Bourc'his, D., Viegas-Pequignot, E., Ehrlich, M., Hanash, S.M. Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum. Mol. Genet. 2000, 9: 597-604.
72. Valko, M., Morris, H., Cronin, M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12: 1161-1208.
73. Seoane, A.I., Guerci, A.M., Dulout, F.N. Malsegregation as a possible mechanism of aneuploidy induction by metal salts in MRC-5 human cells. Environ. Mol. Mutagen. 2002, 40: 20020-6.
74. Guerci, A., Seoane, A., Dulout, F.N. Aneugenic effects of some metal compounds assessed by chromosome counting in MRC-5 human cells. Mutat. Res. 2000, 469: 35-40.
75. Bouilly, K., Gagnaire, B., Bonnard, M., Thomas-Guyon, H., Renault, T., Miramand, P., Lapègue, S. Effects of cadmium on aneuploidy and hemocyte parameters in the Pacific oyster, Crassostrea gigas. Aquat. Toxicol. 2006, 78: 149-156.
76. Loumbourdis, N.S. Hepatotoxic and nephrotoxic effects of cadmium in the frog Rana ridibunda. Arch. Toxicol. 2005, 79: 434-440.
77. Porrier, L.A., Vlasova, T.I. The prospective role of abnormal methyl metabolism in Cadmium toxicity. Environm. Health Perspect. 2002, 110: 793-795.
78. Takiguchi, M., Achanzar, W.E., Qu, W., Li, G., Waalkes, M.P. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 2003, 286: 355-365.
79. Adams, R.L.P. Eukariotic DNA methyltransferases-structure and function. Bioessays 1995, 17: 139-145.
80. Reichard, J.F., Schnekenburger, M., Puga, A. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem. Biophys. Res. Commun. 2007, 352: 188-192.
81. Chen, H., Liu, J., Zhao, C.Q., Diwan, B.A., Merrick, B.A., Waalkes, M.P. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol. Appl. Pharmacol. 2001, 175: 260-268.
82. Chanda, S., Dasgupta, U.B., Guhamazumder, D., Gupta, M., Chaudhuri, U., Lahiri, S., Das, S., Ghosh, N., Chatterjee, D. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci. 2006, 89: 431-437.
83. Biggart, N.W., Costa, M. Assessment of the uptake and mutagenicity of nickel chloride in salmonella tester strains. Mutat. Res. 1986, 175: 209-215.
84. Ohshima, S. Induction of genetic instability and chromosomal instability by nickel sulfate in V79 Chinese hamster cells. Mutagenesis 2003, 18: 133-137.
85. Lee, Y.W., Klein, C.B., Kargacin, B., Salnikow, K., Kitahara, J., Dowjat, K., Zhitkovich, A., Christie, N.T., Costa, M. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol. Cell Biol. 1995, 15: 2547-2557.
86. Lee, Y.W., Broday, L., Costa, M. Effects of nickel on DNA methyltransferase activity and genomic DNA methylation levels. Mutat. Res. 1998, 415: 213-218.
87. Yan, Y., Kluz, T., Zhang, P., Chen, H.B., Costa, M. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. Toxicol. Appl. Pharmacol. 2003, 190: 272-277.
88. Costa, M., Davidson, T.L., Chen, H., Ke, Q., Zhang, P., Yan, Y., Huang, C., Kluz, T. Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat. Res. 2005, 592: 79-88.
89. Chen, H., Ke, Q., Kluz, T., Yan, Y., Costa, M. Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol. Cell Biol. 2006, 26: 3728-3737.
90. Das, K.C., Mohanty, D., Garewal, G. Cytogenetics in nutritional megaloblastic anaemia: prolonged persistence of chromosomal abnormalities in lymphocytes after remission. Acta Haematol. 1986, 76: 146-154.
91. Titenko-Holland, N., Jacob, R.A., Shang, N., Balaraman, A., Smith, M.T. Micronuclei in lymphocytes and exfoliated buccal cells of postmenopausal women with dietary changes in folate. Mutat. Res. 1998, 417: 101-114.
92. Fenech, M., Aitken, C., Rinaldi, J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 1998, 19: 1163-1171.
93. Fenech, M. Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat. Res. 2006, 600: 58-66.
94. Beetstra, S., Salisbury, C., Turner, J., Altree, M., McKinnon, R., Suthers, G., Fenech, M. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency. Carcinogenesis 2006, 27: 517-524.
95. Abramsson-Zetterberg, L., Durling, L.J., Yang-Wallentin, F., Rytter, E., Vessby, B. The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes. Mutat. Res. 2006, 603: 33-40.